Urogen Pharma (NASDAQ:URGN) Receives Average Recommendation of “Moderate Buy” from Brokerages
Urogen Pharma (NASDAQ:URGN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have iss…
ONLY AVAILABLE IN PAID PLANS